Budesonide Oral Inhalation

221 interactions 609 cited references
Also sold as: Pulmicort Pulmicort® Pulmicort® Flexhaler Pulmicort® Respules
About Budesonide Oral Inhalation

Budesonide is used to prevent difficulty breathing, chest tightness, wheezing, and coughing caused by asthma. Budesonide powder for oral inhalation (Pulmicort Flexhaler) is used in adults and children 6 years of age and older. Budesonide suspension (liquid) for oral inhalation (Pulmicort Respules) is used in children 1… Read the full Budesonide Oral Inhalation drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Budesonide Oral Inhalation Nimesulide Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Nimesulide Beta Cyclodextrin Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Nirmatrelvir Increased corticosteroid exposure Details Budesonide Oral Inhalation Norfloxacin An increased risk of tendon rupture Details Budesonide Oral Inhalation Ofloxacin Floxin® An increased risk of tendon rupture Details Budesonide Oral Inhalation Olutasidenib Rezlidhia Reduced sensitive CYP3A substrate exposure Details Budesonide Oral Inhalation Omaveloxolone Skyclarys Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Budesonide Oral Inhalation Oxaprozin Coxanto Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Oxyphenbutazone Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Palbociclib Ibrance Increased budesonide exposure Details Budesonide Oral Inhalation Parecoxib Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Paritaprevir Increased budesonide exposure Details Budesonide Oral Inhalation Pazufloxacin An increased risk of tendon rupture Details Budesonide Oral Inhalation Pefloxacin An increased risk of tendon rupture Details Budesonide Oral Inhalation Phenobarbital Fidoquel Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Budesonide Oral Inhalation Phenylbutazone Equi-Phar Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Phenytoin Dilantin Reduced corticosteroid exposure Details Budesonide Oral Inhalation Piketoprofen Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Piroxicam Feldene Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Pirtobrutinib Jaypirca Increased sensitive CYP3A substrate exposure and an increased risk of sensitive CYP3A substrate-related adverse effects Details Budesonide Oral Inhalation Posaconazole Noxafil Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Oral Inhalation Pranoprofen Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Primidone Mysoline Reduced CYP3A substrate exposure and reduced efficacy of CYP3A substrate Details Budesonide Oral Inhalation Proglumetacin Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Propyphenazone Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Proquazone Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Prulifloxacin An increased risk of tendon rupture Details Budesonide Oral Inhalation Ranitidine Increased budesonide exposure Details Budesonide Oral Inhalation Ranolazine Aspruzyo Increased exposure of CYP3A4 substrate Details Budesonide Oral Inhalation Relacorilant Lifyorli Reduced relacorilant exposure and reduced efficacy of relacorilant, altered (reduced/increased) glucocorticoids exposure, reduced... Details Budesonide Oral Inhalation Ribociclib Kisqali Increased budesonide exposure Details Budesonide Oral Inhalation Ritlecitinib Litfulo Increased CYP3A substrate exposure and an increased risk of CYP3A substrate-related adverse reactions Details Budesonide Oral Inhalation Ritonavir Norvir Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Oral Inhalation Rofecoxib Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Rufloxacin An increased risk of tendon rupture Details Budesonide Oral Inhalation Salicylic Acid Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Salsalate Disalcid Increased risk of gastrointestinal ulcer or bleeding Details Budesonide Oral Inhalation Saquinavir Increased budesonide exposure and an increased risk of budesonide-related adverse effects Details Budesonide Oral Inhalation Sargramostim Leukine Increased myeloproliferative effects of sargramostim Details Budesonide Oral Inhalation Schisandra Sphenanthera Increased budesonide exposure Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.